| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-11-13 | 2025-03-19 | 2024-03-20 | 2023-03-16 | 2022-02-24 | 2020-12-31 | 2019-12-31 |
| Revenue | 180.8 | 203.4 | 259.3 | 321.5 | 383.7 | 364.3 | 233.1 |
| Cost of Revenue | 84.08 | 94.08 | 121.9 | 166.9 | 195.2 | 188.3 | 149.7 |
| Gross Profit | 96.72 | 109.3 | 137.4 | 154.7 | 188.5 | 176 | 83.44 |
| Operating Expenses | 114.8 | 121.6 | 172.6 | 295.6 | 317.4 | 242.5 | 246.6 |
| Research & Development | 10.2 | 18.46 | 16.4 | 22.5 | 23.41 | 18.66 | 13.6 |
| Selling, General and Administrative | 104.6 | 103.2 | 156.2 | 273.1 | 294 | 223.8 | 233 |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.06 | -12.28 | -35.26 | -141 | -128.9 | -66.49 | -163.2 |
| Net Non-Operating Interest | -2.53 | -12.78 | -16.08 | -9.69 | -5.2 | -5.61 | -2.05 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.53 | 12.78 | 16.08 | 9.69 | 5.2 | 5.61 | 2.05 |
| Equity & Other Income/(Expense) | -2.14 | -2.32 | 8.15 | 63.01 | -1.79 | -0.119 | 3.76 |
| Income Before Tax | -22.73 | -27.38 | -43.19 | -87.66 | -135.8 | -72.22 | -161.5 |
| Income Tax Expense | 0.034 | 0.04 | 0.038 | 0.054 | 0.052 | 0.041 | 0.012 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -22.77 | -27.42 | -43.23 | -87.72 | -135.9 | -72.26 | -161.5 |
| Depreciation and Amortization | 3.71 | 9.82 | 5.82 | 5.72 | 4.99 | 4.12 | 2.36 |
| EBITDA | -14.35 | -2.46 | -29.44 | -135.3 | -123.9 | -62.38 | -160.8 |
| Earnings Per Share (EPS) | -0.625 | -0.76 | -1.28 | -4.85 | -4.17 | -2.22 | -0.14 |
| Diluted Earnings Per Share | -0.625 | -0.76 | -1.28 | -4.85 | -4.17 | -2.22 | -0.14 |
| Weighted Average Shares Outstanding | 39.38 | 37.04 | 34.8 | 33.08 | 17.14 | 10.75 | 11.8 |
| Diluted Weighted Average Shares Outstanding | 39.38 | 37.04 | 34.8 | 33.08 | 17.14 | 10.75 | 11.8 |
